ATS 2018 International Conference - Mobile

Cefiderocol (S-649266) for Nosocomial Pneumonia Caused by Gram-Negative Pathogens: Study Design of APEKS-NP, a Phase 3 Double-Blind Parallel-Group Randomized Clinical Trial [Board No. P454]

Location: Board no. P454

Session Type: Thematic Poster Session

Monday

May

21

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Takayuki Katsube

PhD
Shionogi & Co., Ltd.

Tsutae Den Nagata

MD
Shionogi Inc

Mari Ariyasu

PhD
Shionogi & Co., Ltd.

Yuko Matsunaga

MD
Shionogi Inc

Yoshinori Yamano

PhD
Shionogi & Co., Ltd.

Roger Echols

MD
ID3C LLC

View Abstract

Cefiderocol (S-649266) for Nosocomial Pneumonia Caused by Gram-Negative Pathogens: Study Design of APEKS-NP, a Phase 3 Double-Blind Parallel-Group Randomized Clinical Trial

Parent Sessions

B42 - CRITICAL CARE: THE FEVER - INFECTIONS IN THE ICU...
05-21-2018 9:15 AM - 4:15 PM